Analyst Ratings for Karyopharm Therapeutics (KPTI) [Neutrals]

KPTI Rating Summary

KPTI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KPTI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $17.33 (+198.9%) * Over Last 12-Mos
Rating Score: 6.9 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/6/2021 SVB Leerink Jonathan Chang Downgrade Market Perform
(Outperform)
6.00
(N/A)
7.82
(5.80)
-25.83% Details
8/6/2021 RBC Capital Brian Abrahams Downgrade Sector Perform
(Outperform)
8.00
(17.00)
7.82
(5.80)
-25.83% Details
Like KPTI Ratings? Also take a look at REPL

KPTI Ratings News